Conversely, some researchers argue that the m6A eraser ALKBH5, despite its high expression in HCC patients and association with poor outcomes, upregulates MAP3K8 expression by modulating m6A modification, thereby augmenting hepatoma cell proliferation and metastasis. This evidence concerns the gene ALKBH5 and hepatocellular carcinoma.